Skip to search.
 FTSE 100 Down 2.26%

BIND Therapeutics, Inc. (BIND)

-NasdaqGS
4.69 Up 0.24(5.39%) 31 Aug 21:00
Add to Portfolio
Prev Close:4.45
Open:4.47
Bid:4.20 x 500
Ask:4.85 x 200
1y Target Est:17.33
Beta:N/A
Next Earnings Date:N/A
Day's Range:4.35 - 4.85
52wk Range:4.09 - 10.78
Volume:288,812
Avg Vol (3m):132,163
Market Cap:97.30m
P/E (ttm):N/A
EPS (ttm):-1.91
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BIND at this time.

Comparison

Symbol% ChgMkt Cap
BINDUp 5.39%97.30m
PGNXDown 4.43%510.79m
BMYDown 1.88%99.17b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.91
Quarterly EPS Est (Sep-15) :-0.52
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company, develops various targeted and programmable therapeutics. It is developing Accurins that are designed with specific pharmaceutical characteristics intended to target tumors at... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback